London & Capital Asset Management LTD Baxter International Inc Transaction History

London & Capital Asset Management LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $6,344 - $8,379	-170 Reduced 1.24%	13,515 $510,000
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $30,217 - $35,087	-608 Reduced 4.25%	13,685 $697,000
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $98,132 - $121,709	-1,822 Reduced 11.31%	14,293 $770,000
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $6,191 - $7,760	97 Added 0.61%	16,115 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $7,377 - $8,361	-100 Reduced 0.62%	16,018 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $74,221 - $81,145	-922 Reduced 5.41%	16,118 $1.3 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $15,276 - $17,206	-200 Reduced 1.16%	17,040 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $356,594 - $389,562	4,730 Added 37.81%	17,240 $1.38 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $413,582 - $479,054	5,280 Added 73.03%	12,510 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $217,494 - $260,297	-2,765 Reduced 27.66%	7,230 $623,000
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $853,830 - $1.11 Million	-11,930 Reduced 54.41%	9,995 $811,000
Q3 2019 Nov 12, 2019	BUY	$81.4 - $89.78 $687,016 - $757,743	8,440 Added 62.59%	21,925 $1.92 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $717,508 - $805,145	-9,770 Reduced 42.01%	13,485 $1.1 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $106,069 - $133,754	-1,645 Reduced 6.61%	23,255 $1.89 Million
Q4 2018 Feb 14, 2019	BUY	$61.45 - $77.8 $1.53 Million - $1.94 Million	24,900 New	24,900 $1.64 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on London & Capital Asset Management LTD with notifications on news.